SCHEMBL800918

SCHEMBL800918

CC(C)C(=O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17971363 0.76
SCHEMBL2317854 0.76
SCHEMBL9793701 0.76
SCHEMBL620412 0.74 CA1 (0.36)
SCHEMBL181668 0.74 CYP2D6 (0.36)
SCHEMBL11063402 0.73
SCHEMBL12923870 0.73 TSHR (0.40)
SCHEMBL11724354 0.73
SCHEMBL8392171 0.73
SCHEMBL7030509 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113943219-B Method for preparing ketopantoic acid by using dimethyl oxalate 精晶药业股份有限公司 2023-09-22 CN claimed
CN-112154038-B Method for manufacturing silver nanowires 星光PMC株式会社 2023-04-07 CN claimed
CN-113943219-A Method for preparing ketopantoic acid by using dimethyl oxalate 精晶药业股份有限公司 2022-01-18 CN claimed
EP-0912467-B1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE SA (FR) 2002-04-24 EP claimed
EP-0912467-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1999-05-06 EP claimed
WO-1998000375-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1998-01-08 WO claimed
JP-57193489-A None JP disclosed
CN-122055373-A Bridged tricyclic carbamoyl pyridone compounds and uses thereof 吉利德科学公司 2026-05-15 CN disclosed
US-20250120989-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2025-04-17 US disclosed
WO-2025080879-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-04-17 WO disclosed
WO-2025067111-A1 MENIN-MLL INTERACTION INHIBITOR AND PREPARATION METHOD THEREFOR, AND APPLICATION 苏州必扬医药科技有限公司 2025-04-03 WO disclosed
US-11912714-B2 Spiropyrrolidine derived antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2024-02-27 US disclosed
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE LOXO ONCOLOGY, INC. 2024-01-18 US disclosed
EP-0350320-A2 Production of unsaturated compounds PHARMAGLOBE LABORATORIES LTD (CA) 1990-01-10 EP disclosed
EP-0315518-A1 Cephalosporins having in position 3 a substituted vinyl radical, their process for preparation, their application as medicaments, compositions containing them and intermediates ROUSSEL-UCLAF (FR) 1989-05-10 EP disclosed
EP-0298196-A1 Imidazole compounds and biocidal compositions comprising the same ISHIHARA SANGYO KAISHA, LTD. (JP) 1989-01-11 EP disclosed
EP-0295890-A2 Process of preparing optically active alcohol Takasago International Corporation (JP) 1988-12-21 EP disclosed
CN-88101228-A Imidazolium compounds and the biocides that contains this compound that is used for controlling harmful organism 1988-12-07 CN disclosed
EP-0293771-A2 Cephalosporin compound and pharmaceutical composition thereof Kyoto Pharmaceutical Industries, Ltd. (JP) 1988-12-07 EP disclosed
JP-S57193489-A SYN-ISOMER OF 7-SUBSTITUTED-3-CEPHEM-4-CARBOXYLIC ACID ESTER AND ITS PREPARATION FUJISAWA PHARMACEUT CO LTD 1982-11-27 JP disclosed